TOKYO, Jun 11 (Pulse News Wire) – Takara Bio Inc. (4974.T) announced that its ordinary shares will be delisted from the Tokyo Stock Exchange Prime Market effective June 12, 2026, following approval of a share consolidation proposal at the extraordinary shareholders' meeting held on May 20, 2026.
The decision was made in accordance with the listing regulations set forth by the Tokyo Stock Exchange. Details of the share consolidation and related changes can be found in the press release dated May 20, 2026, titled “Approval Resolution Regarding Share Consolidation, Abolition of Unit Share Quantity, and Partial Amendment to Articles of Incorporation.” The company expresses deep gratitude to its shareholders and stakeholders for their long-standing support and understanding throughout the years.
Moving forward, Takara Bio intends to continue striving for enhanced corporate value and societal contributions alongside its parent company, Takara Holdings Co., Ltd.
🟢 Confidence: High AI-translated content.